Large-scale testing (Phase 3)UnknownNCT03192644
What this trial is testing
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 162